ICVTS Click here for other ICVTS advertising opportunities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Interact CardioVasc Thorac Surg 2009;9:588-592. doi:10.1510/icvts.2009.209890
© 2009 European Association of Cardio-Thoracic Surgery

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Salvatore Lentini
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Noto, A.
Right arrow Articles by David, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noto, A.
Right arrow Articles by David, A.

Institutional report - Cardiac general

A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery

Alberto Notoa, Salvatore Lentinib,*, Antonio Versacia, Massimiliano Giardinaa, Domenica Claudia Risitanoa, Roberto Messinaa and Antonio Davida

a Department of Cardiovascular and Thoracic Anaesthesia, Policlinico Universitario G. Martino, University of Messina, Italy
b Department of Cardiac Surgery, Policlinico Universitario G. Martino, University of Messina, Via Consolare Valeria 98100 Messina, Italy

*Corresponding author. Tel.: +390902217081; fax: +390902217086.

E-mail address: salvolentini{at}alice.it (S. Lentini).

Cardiac surgery performed with cardiopulmonary bypass (CPB) may be complicated by hypotension due to low systemic vascular resistance (SVR). Often in those cases, hypotension is resistant to pressor catecholamines. We report six cases of norepinephrine-resistant postcardiotomy hypotension, treated by terlipressin (TP), a potent vasopressor agent. Between May 2007 and May 2008, we treated six patients with TP administration (1 mg bolus) for post CPB refractory vasodilatory hypotension. Analyzed parameters were: mean arterial pressure (m-AP), SVR, cardiac output index (CI), mean pulmonary pressure (m-PP), and lactate, at baseline (before TP bolus) and 3 h after injection. Before TP bolus, the average m-AP was 53.32±8.86 mmHg, the CI was 3.45±0.24 l/min/m2, the SVR was 650±62.03 dyne*s/cm5 and the arterial lactate level was 4.6±0.95 mmol/l. Three hours after the TP bolus, the m-AP increased to 81.83±9.71 mmHg (P=0.002), the CI decreased to 2.88±0.14 l/min/m2 (P=0.002), the SVR increased to 1154±116 dyne*s/cm5 (P=0.002), and arterial lactates decreased to 3.13±0.78 mmol/l (P=0.015), without significant modification of m-PP and CVP. We treated postoperative refractory low SVR hypotension by TP administration in bolus. Exogenous administration of TP normalized SVR and increased the systemic arterial pressure with a minimum effect on pulmonary pressure. Subsequently, the effect on systemic blood pressure enhanced urine output. No major collateral effects were observed. The administration of TP in bolus may result as a useful alternative for treating refractory low SVR hypotension post CPB.

Key Words: Shock (circulatory); Vascular tone and reactivity; CPB; Inflammatory response complications; Postoperative care; Surgery complications







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 European Association for Cardio-thoracic Surgery